Prediction Case File
YouTubePartially Resolved

Tenet Healthcare (THC) and Archrock (AROC): 9/2/26 Bull & Bear

2 extracted signals · 1 resolved · 1 still active

Zacks Investment Research profile imageZacks Investment ResearchIndependent analyst profile
Source published
02 Sept 2026, 13:43 UTC
Recorded by Tahlil Plus
02 Sept 2026, 13:58 UTC
Video preview for Tenet Healthcare (THC) and Archrock (AROC): 9/2/26 Bull & Bear
Source overview

AI-generated source summary

The analysis presents two stocks with a 'bull' and 'bear' designation. Tenet Healthcare Corp (THC) is identified as a 'Strong Buy' with a current price of $267.84, showing a positive intraday change of +0.70%. Archrock Inc (AROC) is designated as a 'Strong Sell' with a current price of $31.68, showing a positive intraday change of +0.54%. The analysis appears to be based on a proprietary ranking system, indicated by the numerical ratings (1 for THC, 5 for AROC) and the 'Strong Buy'/'Strong Sell' labels, rather than explicit technical or fundamental reasoning provided within the clip.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Partially Resolved
Signals
2
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Zacks Investment Research

Platform-wide history, separate from this source evaluation.

Reliability
37.9
Tracked signals
58
Historical success
23.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail